Author

A. Giobbie-Hurder

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:differential expression· 2 Approach:statistical model· 2 Research Focus:variant calling· 2 Assay:whole-exome sequencing· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. E. Kim· 1 shared A. Eichler· 1 shared A. Piris· 1 shared A. R. Thorner· 1 shared A. Roesch· 1 shared A. Wang· 1 shared A. Y. Huang· 1 shared A. Zaremba· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. E. Kim

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma

G. Tarantino, C. A. Ricker, A. Wang, W. Ge, T. J. Aprati, A. Y. Huang, S. Madha, J. Chen, Y. Shi, M. Glettig, D. T. Frederick, S. Freeman, M. M. Holovatska, M. P. Manos, L. Zimmer, , D. Liu

This study identifies genomic heterogeneity and ploidy as markers of intrinsic resistance to PD-1 blockade in metastatic melanoma, with a decision tree model predicting resistance with high confidence.

Science Advances · Nov 29, 2024Peer-reviewedCancer Biology

Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy

A. E. Kim, K. W. Lou, A. Giobbie-Hurder, K. Chang, M. Gidwani, K. Hoebel, J. Patel, M. Cleveland, P. Singh, C. Bridge, S. R. Ahmed, B. Bearce, W. Liu, E. Fuster-Garcia, E. Lee, , E. R. Gerstner

This study links structural and functional vascular dysfunction in brain metastases to pembrolizumab resistance by analyzing perfusion MRI data from 44 patients.

bioRxiv · Aug 25, 2023 · PreprintCancer Biology

Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma

G. J. Starrett, M. Thakuria, T. Chen, C. Marcelus, J. Cheng, J. Nomburg, A. R. Thorner, M. K. Slevin, W. Powers, R. T. Burns, C. Perry, A. Piris, F. C. Kuo, G. Rabinowits, A. Giobbie-Hurder, , J. A. DeCaprio

This study characterizes virus-positive and virus-negative Merkel cell carcinomas using deep sequencing, identifying molecular differences and clinical associations with immunosuppression and survival.

bioRxiv · Mar 24, 2019Cancer Biology